The lenders would need to raise that sum to reach an estimated 10 percent Tier 1 capital ratio, a crucial measure of financial strength, according to Dirk Jaeger, who is responsible for regulatory topics at the group.
The increase in LCA studies forms roughly two categories, between publications relating to regulatory topics, such as packaging, waste and greenhouse gases (Fig. 3), and the wider issues of policy (Fig. 4).
Added a Democratic hill staffer working on regulatory reform topics: "The White House is doing to do what they have to do.
But last month it was forced to drop its $45 billion offer when it ran into regulatory scrutiny.Related topics Arts, entertainment and media Entertainment Satellite television Media Television broadcastingConsolidation is the order of the day in technology and communications industries.
Working tables were arranged to discuss 4 relevant topics: regulatory framework and stakeholder identification, research and monitoring, interagency mechanisms, and identification of projects that will promote a culture of online protection.
The topics included regulatory reform, mortgage refinancing, the "stress tests" that federal regulators are now applying to large banks, and the proposed program to buy their troubled assets.
Although activation of macrophages through the TLR and other pathways and their downstream regulatory programs are popular topics in immunology [4], [5], [6], [7], [8], [9], the global regulatory responses of the innate immune system are largely unknown.
Investigation of casual relationships between genes is one of the crucial topics in regulatory biology.
Noncoding genomics includes single nucleotide polymorphisms (SNPs), regulation of gene expression through DNA methylation of promoter sites, miRNAs, other noncoding RNAs in regulatory regions, and other topics.
In recent months one of the most controversially discussed topics among regulatory agencies, the pharmaceutical industry, journal editors, and academia has been the sharing of patient-level clinical trial data.
As chimeric antigen receptor T cell therapy moves into later-phase clinical trials and becomes an option for more patients, compliance of the chimeric antigen receptor T cell manufacturing process with global regulatory requirements becomes a topic for extensive discussion.
